SMLE infectious diseases questions

Current sepsis guidelines recommend obtaining blood and other relevant cultures before antibiotics, but administration of broad-spectrum empirical antibiotics should not be delayed beyond one hour once septic shock is recognized, since cultures have already been drawn here. Delaying antibiotics to await culture results or imaging increases mortality in septic shock. Fluid resuscitation (30 mL/kg crystalloid) should proceed in parallel, with vasopressors reserved for persistent hypotension after adequate fluids, which has not yet been given here. Early, source-directed antimicrobial therapy combined with aggressive fluid resuscitation forms the cornerstone of the first hour of septic shock management.

• A. Cultures have already been obtained, so there is no reason to delay antibiotics further; waiting risks worsening outcomes.
• B. Vasopressors are indicated only after adequate fluid resuscitation fails to restore perfusion, which has not yet been attempted.
• C. Imaging can be pursued after initial resuscitation and antibiotics; it should not delay empirical therapy in septic shock.

Cefepime, an antipseudomonal fourth-generation cephalosporin, is a standard first-line empirical agent for febrile neutropenia because it provides broad coverage against Pseudomonas aeruginosa and other gram-negative organisms that can cause rapidly fatal infections in neutropenic patients. Ceftriaxone lacks reliable antipseudomonal activity, making it unsuitable as monotherapy in this high-risk setting. Guidelines from IDSA and NCCN recommend an antipseudomonal beta-lactam (cefepime, piperacillin-tazobactam, or a carbapenem) as initial monotherapy in neutropenic fever. Prompt empirical therapy within one hour of presentation is essential given the risk of rapid deterioration.

• A. Ceftriaxone does not reliably cover Pseudomonas aeruginosa, a critical gap in neutropenic fever coverage.
• B. Fluoroquinolones alone are inadequate for empirical treatment of established febrile neutropenia and are used mainly for prophylaxis.
• D. Clindamycin has no useful gram-negative or antipseudomonal activity and is not appropriate empirical monotherapy.

After an unrevealing first-line workup for fever of unknown origin (history, examination, basic labs, blood cultures, chest imaging, urinalysis), the next step is cross-sectional imaging of the chest, abdomen, and pelvis to look for occult abscesses, lymphadenopathy, or malignancy. Empirical antibiotics or steroids should be avoided at this stage because they can mask the underlying disease and delay diagnosis. Bone marrow biopsy is reserved for cases with suggestive hematologic findings or when earlier investigations point toward a marrow process, not as a routine second-line test. A systematic, stepwise approach to FUO improves diagnostic yield and avoids unnecessary invasive procedures.

• A. Bone marrow biopsy is invasive and reserved for later stages or when hematologic abnormalities point toward marrow pathology.
• C. Empirical antibiotics without an identified source risk masking infection and should be avoided in the stepwise FUO approach.
• D. Empirical steroids can suppress infectious or inflammatory signs, hindering further diagnosis, and are not indicated yet.

The standard treatment for uncomplicated brucellosis is a combination regimen to reduce relapse rates, most commonly doxycycline plus rifampin for six weeks, or doxycycline plus intramuscular streptomycin for a shorter course. Monotherapy with doxycycline alone is associated with unacceptably high relapse rates and is not recommended. Combination therapy targets the intracellular survival of Brucella species within the reticuloendothelial system, requiring prolonged dual-agent coverage to achieve cure. Fluoroquinolone or macrolide monotherapy is not considered adequate first-line treatment for brucellosis.

• A. Azithromycin alone for a short course is inadequate for eradicating intracellular Brucella infection.
• B. Ciprofloxacin monotherapy is not a guideline-recommended first-line regimen for brucellosis.
• C. Doxycycline monotherapy has a high relapse rate and is not recommended as sole therapy.

This patient has an epidemiologic risk factor (direct camel contact and unpasteurized camel milk consumption) in an endemic region combined with severe pneumonia, bilateral ground-glass opacities, and lymphopenia, which should raise strong suspicion for Middle East Respiratory Syndrome coronavirus (MERS-CoV) infection. The most sensitive specimen is a lower respiratory tract sample (sputum, bronchoalveolar lavage, or tracheal aspirate) tested by real-time reverse transcriptase PCR, which is the diagnostic test of choice recommended by the Saudi Ministry of Health and WHO. Immediate isolation is essential because of the risk of nosocomial transmission and healthcare worker infection, as seen in prior Saudi outbreaks. Empirical antibiotics for atypical bacterial pneumonia may be given concurrently, but confirming or excluding MERS-CoV takes priority given the epidemiologic risk.

• A. This patient has hypoxemia and risk factors for a potentially fatal, transmissible infection and requires admission and isolation, not discharge.
• C. A standard ward bed without isolation risks nosocomial spread of MERS-CoV; influenza alone does not explain the camel exposure risk.
• D. Tuberculosis does not typically present with this acute course and bilateral ground-glass opacities following camel exposure; MERS-CoV testing should be prioritized.

MERS-CoV is transmitted primarily via respiratory droplets and contact, but during aerosol-generating procedures such as nebulization, suctioning, intubation, or bronchoscopy, airborne transmission risk increases substantially. Saudi MOH and WHO infection prevention guidance therefore recommends placing suspected or confirmed MERS-CoV patients in an airborne infection isolation room (negative pressure) with healthcare workers using fitted N95 (or higher) respirators, eye protection, gowns, and gloves during these procedures. Outside of aerosol-generating procedures, droplet and contact precautions with a well-fitted surgical mask are generally sufficient. Failure to upgrade to airborne precautions during such procedures has been linked to nosocomial outbreaks among healthcare workers in Saudi Arabia.

• A. Droplet precautions with a surgical mask are insufficient during aerosol-generating procedures, which require airborne precautions.
• C. Standard precautions alone are inadequate for a patient undergoing an aerosol-generating procedure with suspected MERS-CoV.
• D. Contact precautions without respiratory protection fail to address the airborne risk created during nebulization or suctioning.

The GeneXpert MTB/RIF assay is a rapid, automated nucleic acid amplification test that detects Mycobacterium tuberculosis DNA and simultaneously identifies rifampin resistance mutations within about two hours, making it the WHO- and Saudi MOH-recommended initial diagnostic test for patients with suspected pulmonary tuberculosis. It has substantially higher sensitivity than smear microscopy, particularly in smear-negative or paucibacillary disease, and provides same-day information that can guide starting standard versus drug-resistant regimens. Sputum smear microscopy is useful for monitoring infectiousness and treatment response but is less sensitive and does not provide resistance data. Culture remains the gold standard for confirmation and full drug susceptibility testing but takes several weeks. Interferon-gamma release assays detect latent infection and cannot distinguish latent from active disease.

• B. Interferon-gamma release assays indicate infection at some point but cannot differentiate active from latent tuberculosis.
• C. Smear microscopy is less sensitive than nucleic acid amplification and does not provide rapid rifampin resistance information.
• D. Culture is the gold standard for confirmation and drug susceptibility testing but takes weeks, delaying initial treatment decisions.

The standard first-line regimen for drug-susceptible pulmonary tuberculosis, as recommended by WHO and adopted in Saudi MOH national TB guidelines, consists of a 2-month intensive phase with isoniazid, rifampin, pyrazinamide and ethambutol, followed by a 4-month continuation phase with isoniazid and rifampin, for a total of 6 months. Pyrazinamide and ethambutol are given in the intensive phase to rapidly reduce bacillary load and prevent the emergence of resistance, then discontinued once the continuation phase begins. This four-drug, 6-month regimen achieves cure rates above 95% in adherent patients with susceptible organisms. Streptomycin is reserved for second-line use or specific resistance patterns, not as routine first-line therapy.

• A. Streptomycin is not part of the standard first-line oral regimen for drug-susceptible tuberculosis; it is reserved for specific resistant cases.
• B. Pyrazinamide should be included from the start of the intensive phase, not added only if sputum remains positive later.
• C. Extending four-drug therapy to 6 months with isoniazid monotherapy afterward is not the standard regimen and unnecessarily prolongs toxic drug exposure.

Isoniazid inhibits pyridoxine (vitamin B6) metabolism by forming a complex with it and increasing its urinary excretion, leading to functional pyridoxine deficiency. Pyridoxine is a required cofactor for glutamate decarboxylase, which synthesizes the inhibitory neurotransmitter GABA, and for other enzymes involved in myelin and neurotransmitter synthesis; its deficiency results in a dose-dependent peripheral sensorimotor neuropathy. This risk is higher in patients with diabetes mellitus, malnutrition, chronic kidney disease, HIV infection, pregnancy, or alcohol use, which is why prophylactic pyridoxine supplementation is recommended in these groups. Ethambutol's major adverse effect is optic neuritis rather than peripheral neuropathy, and rifampin and pyrazinamide are not primarily associated with this mechanism.

• B. Pyrazinamide causes hyperuricemia and arthralgia, not peripheral neuropathy through nerve ischemia.
• C. Ethambutol is classically associated with optic neuritis, not peripheral sensory neuropathy.
• D. Rifampin is not associated with autoimmune demyelinating peripheral neuropathy; its adverse effects relate to hepatotoxicity and drug interactions.

Rifampin is a potent inducer of hepatic cytochrome P450 enzymes, particularly CYP3A4, which increases the metabolic clearance of many drugs metabolized through this pathway, including the estrogen and progestin components of combined oral contraceptives. This enzyme induction lowers plasma concentrations of the contraceptive hormones below the threshold needed for reliable ovulation suppression, increasing the risk of unintended pregnancy and breakthrough bleeding. Women taking rifampin should be counseled to use an alternative or additional non-hormonal method of contraception, such as barrier methods or an intrauterine device, during treatment and for a period afterward. This CYP450 induction mechanism also underlies rifampin's interactions with warfarin, antiretrovirals, and antifungal azoles.

• A. Rifampin does not act as a direct receptor antagonist; its interaction is pharmacokinetic through enzyme induction.
• B. Rifampin's interaction with oral contraceptives is hepatic enzyme induction, not altered gastrointestinal motility or absorption.
• C. Rifampin does not significantly act through plasma protein displacement to reduce contraceptive efficacy.

A positive interferon-gamma release assay is not affected by prior BCG vaccination and confirms Mycobacterium tuberculosis infection in this asymptomatic healthcare worker with a normal chest X-ray, indicating latent tuberculosis infection rather than active disease. Before starting preventive therapy, active disease must be excluded clinically and radiologically, which has been done here. Standard management for latent TB infection in an immunocompetent adult is isoniazid monotherapy for 6 to 9 months (commonly 6 months per many national programs including Saudi MOH), given with pyridoxine to reduce the risk of peripheral neuropathy. Treating latent infection in healthcare workers reduces their risk of progression to active disease and further transmission.

• A. Observation without treatment is inappropriate for confirmed latent infection in a healthcare worker, who is at ongoing risk of reactivation and transmission.
• C. The full four-drug regimen for active disease is unnecessary and inappropriate; active TB has been excluded, so preventive monotherapy is indicated.
• D. A positive interferon-gamma release assay is not confounded by BCG vaccination and indicates true infection requiring further management, not reassurance alone.

Viral meningitis typically produces a lymphocyte-predominant pleocytosis with mildly elevated protein and a normal CSF-to-serum glucose ratio, as seen here with a CSF glucose of 3.1 mmol/L against a serum glucose of 5.5 mmol/L, giving a ratio above 0.5. Acute bacterial meningitis instead causes marked neutrophilic pleocytosis, high protein, and low glucose due to bacterial consumption. Tuberculous meningitis classically shows a lymphocytic pleocytosis but with markedly elevated protein and a low glucose, often evolving over days to weeks. The normal glucose ratio and only mildly elevated protein in this case point away from a bacterial or granulomatous process.

• A. Fungal meningitis, like TB, usually presents with lower glucose and higher protein, and typically occurs in immunocompromised patients with a more indolent course.
• B. Bacterial meningitis would show a neutrophil-predominant pleocytosis with markedly low glucose, which is not seen here.
• C. TB meningitis typically shows a lower CSF glucose and higher protein, with a more subacute clinical course over days to weeks.

Focal neurological deficits, a dilated unreactive pupil, and bradycardia with hypertension are signs of raised intracranial pressure and possible impending herniation, making lumbar puncture unsafe until mass lesion or significant brain shift is excluded. Current guidelines recommend obtaining neuroimaging first in such patients, but antibiotics (and dexamethasone if indicated) should never be delayed for imaging and should be given empirically based on blood cultures drawn beforehand. Withholding antibiotics while awaiting imaging or LP risks a worse outcome from the underlying infection. Mannitol is not a substitute for antimicrobial therapy and should not delay empirical treatment.

• A. Performing LP in a patient with signs of raised intracranial pressure risks brain herniation and is contraindicated until imaging excludes a mass effect.
• C. Mannitol does not treat the underlying infection, and antibiotics must not be delayed for any imaging or additional treatment.
• D. Antibiotics should be started immediately in this patient, but LP should only proceed after CT has excluded a contraindication, not simply after cultures return.

Close contacts of a confirmed meningococcal meningitis case, including household members, roommates, and those with direct exposure to oral secretions, require chemoprophylaxis as soon as possible, ideally within 24 hours of diagnosis, to eradicate nasopharyngeal carriage and prevent secondary cases. Oral rifampicin twice daily for 2 days is a standard regimen; alternatives include a single dose of ciprofloxacin or intramuscular ceftriaxone. Chemoprophylaxis is recommended regardless of vaccination status because it acts rapidly, while vaccination provides longer-term protection. Observation alone is inappropriate given the significant risk of secondary disease in close contacts.

• A. Amoxicillin does not reliably eradicate nasopharyngeal meningococcal carriage and is not a recommended prophylactic agent for this purpose.
• C. Benzathine penicillin is not used for meningococcal chemoprophylaxis as it does not reliably clear nasopharyngeal carriage.
• D. Close contacts are at substantially increased risk of secondary meningococcal disease, and prophylaxis should be given promptly rather than waiting for symptoms.

Adjunctive dexamethasone should be given shortly before or concurrently with the first dose of antibiotics, as this timing has been shown to reduce mortality and neurological complications, particularly in pneumococcal meningitis in adults. The proposed mechanism is that dexamethasone blunts the inflammatory response to bacterial lysis products released once antibiotics begin killing bacteria; giving it after antibiotics have already triggered this inflammatory cascade diminishes its benefit. Starting dexamethasone late offers little to no benefit and is not recommended once significant antibiotic-induced lysis has occurred. If the causative organism is later found not to be Streptococcus pneumoniae or Haemophilus influenzae, dexamethasone can be discontinued.

• B. Dexamethasone is given prophylactically with the first antibiotic dose to reduce inflammatory complications, not reactively after cerebral edema has developed.
• C. Delaying dexamethasone by several hours after antibiotics are started significantly reduces its effectiveness compared to giving it with the first dose.
• D. Giving dexamethasone after completing antibiotics provides no benefit since the inflammatory cascade from bacterial lysis has already occurred.

Fever, altered mental status, new focal neurological findings such as aphasia, seizures, and temporal lobe involvement on MRI are highly suggestive of herpes simplex encephalitis, which has a predilection for the temporal and frontal lobes due to the virus's route of entry via the olfactory and trigeminal pathways. Because untreated HSV encephalitis carries high mortality and morbidity, empirical intravenous acyclovir must be started immediately based on clinical and radiological suspicion, without waiting for confirmatory CSF HSV PCR, which remains the diagnostic gold standard but can take time to return. Lumbar puncture should still be performed promptly to send PCR and guide further management, but treatment should never be delayed for results. Brain biopsy is reserved for atypical or refractory cases, not for initial diagnosis or treatment decisions.

• A. Delaying acyclovir until PCR confirmation significantly worsens outcomes given the high mortality of untreated HSV encephalitis; treatment should be empirical.
• B. Brain biopsy is invasive and reserved for cases that do not respond to treatment or remain diagnostically unclear; it is not the immediate next step.
• D. Antibacterial therapy alone does not address the clinical picture, which is classic for a viral, not bacterial, encephalitis.

New-onset watery diarrhea occurring after recent antibiotic exposure, particularly fluoroquinolones, clindamycin, or broad-spectrum penicillins and cephalosporins, in a hospitalized patient should raise strong suspicion for Clostridioides difficile infection. The recommended diagnostic approach combines a sensitive screening test, glutamate dehydrogenase antigen or nucleic acid amplification testing, with a specific toxin enzyme immunoassay to confirm active toxin-mediated disease rather than mere colonization. Antibiotic exposure disrupts normal colonic flora, allowing C. difficile overgrowth and toxin production leading to colitis. Routine stool culture and ova and parasite testing have low yield in this clinical context and are not first-line, while colonoscopy is reserved for diagnostic uncertainty or suspected complications, not as an initial test.

• B. Ova and parasite testing is not indicated in acute hospital-acquired diarrhea following antibiotic use and has very low diagnostic yield in this setting.
• C. Colonoscopy is invasive and reserved for cases with diagnostic uncertainty or suspected fulminant colitis, not as the initial test for suspected C. difficile infection.
• D. Routine stool culture for enteric pathogens such as Salmonella or Shigella has low yield in antibiotic-associated diarrhea and is not the recommended first test.

Amoebic liver abscess classically presents as a single, large lesion in the right lobe of the liver with positive Entamoeba histolytica serology, typically in a younger patient from an endemic area with a short symptomatic history and mild leukocytosis without jaundice. Pyogenic liver abscess more often is multiple or multiloculated, associated with biliary tract disease or bacteremia, and commonly yields organisms such as Klebsiella pneumoniae or E. coli on aspirate culture. The absence of jaundice and biliary pathology here further supports an amoebic rather than biliary source. Serology has high sensitivity and specificity for invasive amoebiasis in this clinical context.

• A. Ascending cholangitis with ductal dilation points to a biliary source typical of pyogenic abscess, not amoebic disease.
• B. Multiple abscesses are more typical of pyogenic liver abscess, often from biliary or portal spread.
• D. Klebsiella pneumoniae is a classic causative organism of pyogenic liver abscess, not amoebic abscess.

A positive HBsAg beyond 6 months defines chronic hepatitis B infection; positive HBeAg indicates active viral replication and high infectivity, which correlates with high HBV DNA levels. Positive anti-HBc IgG reflects past or ongoing exposure to the virus, while a negative anti-HBs confirms the patient has not cleared the infection or developed protective immunity. This serologic pattern, HBsAg-positive and HBeAg-positive, is seen in the immune-tolerant or immune-active phase of chronic hepatitis B, depending on ALT and HBV DNA levels. Resolved infection would show negative HBsAg with positive anti-HBs and anti-HBc.

• A. Vaccination produces isolated positive anti-HBs without positive HBsAg or anti-HBc, which contradicts this panel.
• B. The window period refers to a phase between disappearance of HBsAg and appearance of anti-HBs, when only anti-HBc is positive; here HBsAg is clearly positive.
• C. Resolved infection requires a negative HBsAg and positive anti-HBs, which are not seen here.

Infants born to HBsAg-positive mothers should receive both the hepatitis B vaccine and hepatitis B immune globulin (HBIG) within 12 hours of birth, administered at separate injection sites, to maximize prevention of perinatal transmission. This combined approach is more than 90% effective at preventing chronic hepatitis B infection in the infant, which can occur in up to 90% of untreated exposed neonates if the mother is also HBeAg-positive. The vaccine series continues on the routine schedule afterward. Waiting for maternal HBeAg results would delay time-critical prophylaxis, since HBIG and vaccine should not be withheld pending this test.

• B. Prophylaxis must not be delayed for maternal HBeAg testing, since both agents should be given within 12 hours of birth regardless of HBeAg status.
• C. Vaccine should not be delayed to 6 months; both HBIG and the first vaccine dose are needed within 12 hours of birth.
• D. Vaccine alone is insufficient for infants of HBsAg-positive mothers; HBIG is also required for optimal protection against perinatal transmission.

Current guidelines from AASLD/IDSA and WHO recommend direct-acting antiviral (DAA) regimens, such as sofosbuvir-velpatasvir or glecaprevir-pibrentasvir, as first-line treatment for chronic hepatitis C, achieving sustained virologic response rates above 95% with short treatment durations of 8 to 12 weeks. These regimens target viral proteins such as NS3/4A protease, NS5A, and NS5B polymerase, interrupting viral replication with minimal side effects compared to older regimens. Interferon-based therapy is now obsolete due to its toxicity, longer duration, and lower efficacy. Ribavirin monotherapy has no role in hepatitis C treatment, and tenofovir is used for hepatitis B, not hepatitis C.

• A. Interferon-based regimens have been replaced by DAAs due to superior efficacy and tolerability of the latter.
• C. Ribavirin monotherapy is not an effective treatment for chronic hepatitis C and is only used as an adjunct in specific DAA regimens.
• D. Tenofovir is an antiviral used for chronic hepatitis B, not for hepatitis C, which is unrelated to its mechanism of action.

The blood film finding of multiple small ring forms, frequent multiple infection of a single erythrocyte, normal-sized infected red cells, and absence of schizonts or gametocytes in peripheral smear is characteristic of Plasmodium falciparum. Given travel to sub-Saharan Africa, an area with widespread chloroquine-resistant P. falciparum, treatment should proceed empirically with an artemisinin-based combination therapy rather than chloroquine. P. vivax and P. malariae typically show enlarged infected erythrocytes (vivax) or band forms (malariae) and rarely multiple parasites per cell. Serologic confirmation is not needed and would dangerously delay treatment of a potentially severe falciparum infection.

• A. P. malariae often shows band-form trophozoites and typically infects a single parasite per cell, not the pattern described.
• B. Serologic testing is not required and would dangerously delay treatment of potentially life-threatening falciparum malaria.
• C. P. vivax infects and enlarges reticulocytes, usually with a single parasite per cell and visible schizonts, unlike this pattern.

This patient has severe falciparum malaria, defined by impaired consciousness, hyperlactatemia, acute kidney injury, shock and parasitemia over 5%. WHO and current guidelines recommend intravenous artesunate as first-line therapy for severe malaria in both adults and children, as it clears parasitemia faster and reduces mortality compared with quinine. Artesunate is given intravenously at 2.4 mg/kg at 0, 12 and 24 hours, then daily, followed by a full oral course once the patient can tolerate oral medication. Oral agents are inappropriate in a patient with shock and altered mentation who may not absorb or tolerate them reliably.

• A. Quinine is an alternative only when artesunate is unavailable; it is inferior in mortality benefit and more toxic (cinchonism, hypoglycemia).
• B. Oral therapy is reserved for uncomplicated malaria; this patient has organ dysfunction and shock requiring parenteral treatment.
• C. Chloroquine is ineffective against resistant P. falciparum and is not used for severe disease.

This patient has dengue with warning signs (abdominal pain, vomiting, rising hematocrit with falling platelets), indicating risk of progression to severe dengue with plasma leakage. The critical principle is careful isotonic crystalloid resuscitation (e.g., Ringer's lactate or normal saline), titrated to hematocrit trend, urine output and hemodynamic status, avoiding both under- and over-resuscitation since capillary leak can cause fluid overload. Platelet transfusion is not given prophylactically based on count alone; it is reserved for significant active bleeding. Hypotonic fluids are inappropriate because they do not adequately expand the intravascular space during capillary leak.

• A. Hypotonic fluids are inadequate for intravascular volume expansion and risk hyponatremia.
• B. Platelet transfusion is not indicated for thrombocytopenia alone without significant bleeding.
• C. Withholding fluids risks progression to hypovolemic shock from plasma leakage.

The NS1 antigen is detectable from day 1 of symptom onset up to about day 7-9, making it the most sensitive test during the early febrile phase of dengue, as in this patient on day 2 of illness. IgM antibodies typically become detectable only after day 5, and IgG rises later, reflecting past or convalescent infection rather than acute disease. Paired serology confirms infection retrospectively but is not useful for immediate clinical decision-making. Choosing the correct test according to illness day is essential for timely diagnosis and triage.

• A. Paired serology is used for retrospective confirmation, not acute diagnosis.
• B. IgG reflects past exposure or later convalescent response, not early acute infection.
• D. IgM is usually not yet detectable this early (before day 5 of illness).

Cutaneous leishmaniasis is endemic in parts of Saudi Arabia, particularly Al-Ahsa and the central region, and is transmitted by the bite of infected female sandflies (Phlebotomus species). The classic presentation is a painless papule at the bite site that slowly evolves over weeks into a well-demarcated ulcer with raised, indurated borders, often with little associated systemic illness, as described here. Diagnosis is confirmed by demonstrating amastigotes on a skin smear or biopsy from the ulcer edge. Anthrax typically produces a painless black eschar with marked surrounding edema, usually after contact with livestock or animal products, while sporotrichosis and bacterial furuncles present differently and lack the characteristic sandfly exposure history.

• A. Sporotrichosis is associated with gardening or plant/thorn injuries and usually shows nodular lymphangitic spread, not a solitary indurated ulcer from sandfly exposure.
• C. Cutaneous anthrax presents with a black eschar and marked edema, typically following contact with animal hides or livestock, not sandfly bites.
• D. A furuncle is a painful, fluctuant, pus-filled nodule from bacterial folliculitis, not a chronic painless ulcer.

Doxycycline, a tetracycline-class antibiotic, is the treatment of choice for acute Q fever caused by Coxiella burnetii, an obligate intracellular bacterium transmitted through contact with infected livestock (sheep, goats, cattle) or inhalation of contaminated aerosols during parturition. Tetracyclines work by binding the 30S ribosomal subunit and inhibiting bacterial protein synthesis, and are effective against this intracellular organism, typically given for 14 days in acute disease. Beta-lactams like amoxicillin are ineffective against Coxiella because it lacks a typical peptidoglycan cell wall target accessible to these agents, and fluoroquinolones and metronidazole are not first-line for this pathogen.

• A. Fluoroquinolones are an alternative in some settings but are not the first-line agent for acute Q fever.
• C. Metronidazole has no activity against Coxiella burnetii; it is used for anaerobic and protozoal infections.
• D. Beta-lactams are ineffective against intracellular organisms like Coxiella burnetii.

The Saudi Ministry of Health mandates quadrivalent meningococcal ACWY vaccination for all Hajj and Umrah pilgrims because of the historically documented risk of meningococcal outbreaks associated with mass gatherings in Mecca and Medina, with proof of vaccination required within the preceding 3 years (or valid duration) as a visa condition. Seasonal influenza vaccination is also recommended, especially for high-risk groups, but is not mandatory. Hepatitis A and typhoid vaccines are recommended for travelers to endemic regions generally but are not Hajj-specific requirements, and yellow fever vaccination is only required for pilgrims arriving from yellow-fever-endemic countries.

• A. Typhoid vaccine is advisable for general travel hygiene risk but is not mandated for Hajj entry.
• C. Yellow fever vaccine is only required for pilgrims coming from countries with yellow fever transmission risk, not universally mandatory.
• D. Hepatitis A vaccine is a general travel recommendation, not a mandatory Hajj requirement.

This patient has clinical features of meningococcemia with septic shock: fever, meningismus, a rapidly spreading non-blanching purpuric rash and hypotension, a presentation with high short-term mortality if treatment is delayed. Current guidelines emphasize that empirical intravenous antibiotics (ceftriaxone) must be given immediately on clinical suspicion, without waiting for lumbar puncture, blood culture results, or confirmatory testing, since delay significantly worsens outcomes. Blood cultures can be drawn simultaneously if this does not delay antibiotic administration, but lumbar puncture is deferred given hemodynamic instability and risk of herniation. Oral antibiotics and outpatient monitoring are inappropriate given the severity of shock and risk of rapid deterioration.

• A. Antibiotics should not be delayed for investigations when shock and purpura indicate fulminant meningococcemia.
• B. Waiting for PCR confirmation risks fatal delay in a rapidly progressive, life-threatening infection.
• D. Oral antibiotics and outpatient monitoring are inadequate for a patient in septic shock with purpura fulminans.

Respiratory droplet and aerosol transmission is the dominant route for influenza, coronaviruses and other respiratory pathogens that circulate during mass gatherings like Hajj. Mask use in crowded, poorly ventilated settings reduces exhalation and inhalation of infectious droplets and is a core recommendation of the Saudi MOH and WHO for pilgrims, alongside hand hygiene and cough etiquette. Vitamin C supplementation has no proven benefit in preventing respiratory infection. Giving antipyretics to febrile pilgrims so they keep mixing with crowds would increase transmission, not reduce it. Ablution is a religious practice with no established role in interrupting droplet or airborne spread.

• A. Ablution improves hygiene generally but does not interrupt droplet/airborne respiratory transmission.
• B. Masking fever rather than isolating febrile individuals increases the risk of ongoing transmission.
• C. Vitamin C has no proven efficacy in preventing respiratory tract infections.

Pain disproportionate to the apparent severity of skin findings, together with crepitus from subcutaneous gas-forming organisms, hemorrhagic bullae, and rapidly progressive systemic toxicity, are classic red flags for necrotizing fasciitis rather than simple cellulitis. Cellulitis typically causes tenderness proportionate to the degree of erythema and warmth, without crepitus or bullae. Fever and tachycardia can occur in both conditions and are not discriminating alone. Recognizing these red flags is critical because necrotizing fasciitis requires emergent surgical exploration, unlike cellulitis which is managed with antibiotics alone.

• A. Mild, proportionate tenderness is expected in simple cellulitis, unlike the severe disproportionate pain of necrotizing fasciitis.
• B. Fever and tachycardia can occur in severe cellulitis as well and are not specific for necrotizing fasciitis.
• D. Localized erythema and warmth are typical of uncomplicated cellulitis and do not distinguish it from necrotizing fasciitis.

This patient has clinical features highly suggestive of necrotizing fasciitis: rapidly progressive skin discoloration, crepitus, hypotension, and laboratory markers of severe sepsis with hyponatremia and renal impairment, consistent with a high LRINEC-type risk profile. Once the diagnosis is clinically suspected, emergency surgical debridement should not be delayed for imaging, as early source control is the single most important determinant of survival. MRI may be used in equivocal cases but delays definitive treatment and is not appropriate when clinical suspicion is already high with hemodynamic instability. Hyperbaric oxygen and intravenous immunoglobulin may be considered as adjuncts in select cases but never replace or precede emergency debridement.

• B. Imaging delays definitive surgical source control and is unnecessary when clinical suspicion is already high with hemodynamic instability.
• C. Intravenous immunoglobulin may be used as adjunctive therapy in toxic shock-associated necrotizing infection but does not replace emergency surgery.
• D. Hyperbaric oxygen is only an adjunct and must never substitute for or delay emergency surgical debridement.

This patient has a purulent skin and soft tissue infection with a history suggesting close-contact spread, a classic risk factor for community-acquired MRSA (CA-MRSA). After incision and drainage, oral trimethoprim-sulfamethoxazole (or doxycycline) is recommended empirical coverage for CA-MRSA according to IDSA skin and soft tissue infection guidelines. Amoxicillin-clavulanate and cephalexin provide good coverage against methicillin-sensitive Staphylococcus aureus and streptococci but do not reliably cover MRSA. Azithromycin has high rates of macrolide resistance among staphylococci and is not recommended for MRSA-risk purulent infections.

• A. Cephalexin is a beta-lactam that lacks activity against MRSA.
• B. Amoxicillin-clavulanate does not reliably cover methicillin-resistant Staphylococcus aureus.
• C. Azithromycin has unreliable activity against Staphylococcus aureus due to high rates of macrolide resistance.

A positive probe-to-bone test in a diabetic foot ulcer substantially raises the probability of underlying osteomyelitis and should prompt imaging confirmation. Plain radiography is the recommended initial imaging study because it is widely available and can show cortical destruction, periosteal reaction, or sequestrum, though it has limited sensitivity early in the disease course. Magnetic resonance imaging is the most sensitive and specific modality and should be obtained when plain films are normal or equivocal but clinical suspicion remains high. Superficial wound swabs frequently grow colonizing organisms rather than the true pathogens causing bone infection, and procalcitonin is not validated for diagnosing diabetic foot osteomyelitis. Doppler ultrasound assesses vascular supply but does not establish or exclude bone infection.

• B. Doppler ultrasound evaluates arterial perfusion, not the presence of bone infection.
• C. Procalcitonin is not a validated or reliable test for diagnosing diabetic foot osteomyelitis.
• D. Superficial swab cultures reflect surface colonizing flora and correlate poorly with the true causative organism of osteomyelitis.

A synovial fluid white blood cell count above 50,000/microliter with a strong neutrophilic predominance is highly suggestive of septic arthritis, even though Gram stain is negative in a substantial proportion of culture-proven cases (sensitivity of Gram stain in septic arthritis is only about 50-75%). Empirical antibiotics should be started while awaiting culture results, and the joint should be managed as septic until proven otherwise. Gout typically produces lower white cell counts with negatively birefringent crystals on polarized microscopy, which were not described here. Osteoarthritis and rheumatoid arthritis flares typically produce much lower synovial white cell counts (generally under 2,000/microliter and 2,000-50,000/microliter respectively, usually without this degree of acute systemic toxicity) and would not explain this picture.

• B. Osteoarthritis produces much lower synovial white cell counts (typically under 2,000/microliter) without this degree of neutrophilic inflammation.
• C. Gout would show lower cell counts with negatively birefringent needle-shaped crystals, not described here, and a negative Gram stain does not favor gout.
• D. Rheumatoid arthritis flares usually produce lower white cell counts than seen here, and this acute presentation with fever is atypical.

This woman has classic symptoms and signs of uncomplicated acute cystitis: isolated lower urinary tract symptoms without fever or flank pain, in a non-pregnant woman with no structural or functional urologic abnormality. First-line empirical treatment is a short course of oral nitrofurantoin (or trimethoprim-sulfamethoxazole where local resistance is low), and treatment can be started empirically without waiting for urine culture or performing imaging. Intravenous antibiotics and hospital admission are reserved for pyelonephritis with systemic toxicity or inability to tolerate oral intake, neither of which applies here. A prolonged 14-day fluoroquinolone course with renal imaging would be appropriate for complicated pyelonephritis, not simple cystitis, and is overtreatment in this case.

• A. Intravenous therapy and admission are reserved for pyelonephritis with systemic toxicity, which this patient does not have.
• B. Empirical antibiotic therapy should be started for symptomatic uncomplicated cystitis without waiting for culture results.
• C. A prolonged fluoroquinolone course and renal imaging are appropriate for complicated pyelonephritis, not uncomplicated cystitis, and represent overtreatment here.

Asymptomatic bacteriuria in pregnancy is defined as a positive urine culture (≥10^5 CFU/mL of a single organism) without symptoms, confirmed on two consecutive samples in non-catheterized women. Unlike in non-pregnant women, it must always be treated because of the risk of progression to pyelonephritis, preterm labor, and low birth weight. A short course of an appropriate antibiotic such as nitrofurantoin (avoided near term) or amoxicillin based on sensitivity is indicated once confirmed. Imaging is not required for an isolated episode with a normal exam.

• A. Renal imaging is not indicated for an isolated episode of asymptomatic bacteriuria without recurrent infection or other red flags.
• B. Prophylactic antibiotics for the entire pregnancy are reserved for recurrent infections or specific risk factors, not a first isolated episode.
• D. Untreated asymptomatic bacteriuria in pregnancy significantly increases the risk of pyelonephritis and adverse pregnancy outcomes, so observation is inappropriate.

This patient has secondary syphilis, marked by the rash on palms and soles and prior painless chancre (primary stage). The acute febrile illness with myalgia and rash exacerbation after penicillin treatment is the Jarisch-Herxheimer reaction, caused by rapid lysis of large numbers of Treponema pallidum releasing lipoproteins and other pyrogenic components that trigger a burst of cytokines such as TNF-alpha and IL-6. It is self-limited, typically resolving within 24 hours, and is not an allergic reaction, so penicillin should not be discontinued. Antipyretics are used for symptomatic relief.

• A. An IgE-mediated allergic reaction would present with urticaria, angioedema, or anaphylaxis rather than fever and myalgia shortly after antibiotic lysis of spirochetes.
• B. Penicillin does not typically cause acute hepatotoxicity, and this would not explain the temporal link to antitreponemal therapy.
• D. Immune complex deposition causes serum sickness-like reactions days to weeks later, not an acute reaction within hours of treatment.

The diagnosis of pelvic inflammatory disease here is based on the minimum criteria: lower abdominal tenderness, cervical motion tenderness, and adnexal tenderness in a sexually active woman with no other identified cause, often with fever and purulent discharge supporting the diagnosis. Repeated or severe episodes cause scarring and adhesions within the fallopian tubes, which impair normal transport of the fertilized ovum and increase the risk of ectopic pregnancy, along with tubal factor infertility and chronic pelvic pain. This complication arises directly from structural damage to tubal mucosa and architecture, not from a separate oncologic or endometrial process.

• B. Chronic pelvic inflammation from PID is not an established direct cause of ovarian malignancy.
• C. Cervical intraepithelial neoplasia is primarily driven by persistent high-risk HPV infection, not by pelvic inflammatory disease.
• D. Uterine fibroids are benign smooth muscle tumors unrelated to the inflammatory damage caused by ascending genital infection.

Current guidelines recommend that antiretroviral therapy be initiated in all individuals diagnosed with HIV infection regardless of CD4 count, because early treatment reduces morbidity, mortality, and onward transmission, consistent with the 'treat all' and 'undetectable = untransmittable' strategies. The only prerequisite is that the patient understands the diagnosis and the importance of lifelong adherence before starting. A typical first-line regimen combines two nucleoside reverse transcriptase inhibitors with an integrase strand transfer inhibitor, chosen for high potency, tolerability, and a high barrier to resistance. Waiting for a CD4 threshold or viral load cutoff is outdated practice associated with worse outcomes.

• B. Deferring treatment until CD4 falls below 500 cells/microliter reflects outdated threshold-based strategies, not current universal treatment recommendations.
• C. Waiting until CD4 falls below 200 cells/microliter risks opportunistic infections and reflects outdated guidance before universal early treatment was adopted.
• D. Viral load threshold is not used to decide when to start therapy; all diagnosed patients are offered immediate treatment.

Prophylaxis against Pneumocystis jirovecii pneumonia is indicated when the CD4 count falls below 200 cells/microliter, and trimethoprim-sulfamethoxazole is the first-line agent because it is highly effective, inexpensive, and also provides some protection against toxoplasmosis. Prophylaxis can be discontinued once the CD4 count rises above 200 cells/microliter for at least three months on effective antiretroviral therapy. Azithromycin prophylaxis for Mycobacterium avium complex is reserved for CD4 counts below 50 cells/microliter and is no longer routinely recommended with early antiretroviral therapy. Fluconazole and valganciclovir are not used as primary prophylaxis at this CD4 threshold.

• A. Routine antifungal prophylaxis with fluconazole is not recommended at this CD4 level due to concerns about resistance and limited benefit.
• C. Azithromycin prophylaxis targets Mycobacterium avium complex and is indicated at a much lower CD4 threshold, around 50 cells/microliter.
• D. Valganciclovir is used for cytomegalovirus disease prevention or treatment, typically relevant at much lower CD4 counts, not routinely at 180 cells/microliter.

Cryptococcal meningitis typically occurs at CD4 counts below 100 cells/microliter and presents with a subacute course of headache, fever, and altered mental status, often with elevated cerebrospinal fluid opening pressure reflecting raised intracranial pressure. The India ink stain demonstrating encapsulated yeast forms is classic for Cryptococcus neoformans, and this can be confirmed with cryptococcal antigen testing or fungal culture. Management requires induction therapy with amphotericin B and flucytosine, followed by fluconazole consolidation, along with control of intracranial pressure. Toxoplasmosis and CMV typically show focal neurological deficits or characteristic imaging findings rather than this India ink-positive meningitic picture.

• B. Progressive multifocal leukoencephalopathy, caused by JC virus, presents with focal neurological deficits and white matter lesions on imaging, not with yeast forms on CSF staining.
• C. Cerebral toxoplasmosis classically presents with focal neurological deficits and multiple ring-enhancing lesions on imaging, not an India ink-positive yeast picture on CSF.
• D. Cytomegalovirus encephalitis typically occurs at very low CD4 counts and presents with a more diffuse encephalopathic picture, and CSF would not show encapsulated yeast forms.

Occupational exposure to blood from an HIV-positive source through a hollow-bore needle is classified as a high-risk percutaneous exposure regardless of the source's current viral load, since undetectable plasma viral load does not guarantee absence of transmission risk and viral load can fluctuate. Post-exposure prophylaxis (PEP) should be started as soon as possible, ideally within 2 hours and no later than 72 hours after exposure, using a three-drug regimen (commonly tenofovir, emtricitabine, and raltegravir or dolutegravir) continued for 28 days. Delaying PEP to await further test results or giving an inadequate regimen reduces its effectiveness. Baseline and follow-up HIV testing are done, but they do not replace timely initiation of prophylaxis.

• B. Waiting for additional results delays PEP beyond the window of maximum effectiveness and is not recommended.
• C. A single-drug regimen is suboptimal; current guidelines recommend a three-drug regimen for occupational PEP.
• D. An undetectable viral load lowers but does not eliminate transmission risk, so PEP is still indicated after a significant exposure.

Pulmonary tuberculosis is transmitted by small airborne droplet nuclei (less than 5 micrometers) that remain suspended in air and can travel beyond 1 meter, requiring airborne precautions. These include placement in a negative-pressure room with at least 6-12 air changes per hour, use of a fit-tested N95 respirator by healthcare workers, and keeping the door closed. Contact precautions address pathogens spread by direct or indirect touch, such as multidrug-resistant organisms or Clostridioides difficile. Droplet precautions are used for larger respiratory droplets that travel only short distances, as with influenza or meningococcal meningitis. Protective isolation is reserved for severely immunocompromised patients to prevent them from acquiring infection.

• A. Protective isolation protects an immunocompromised patient from external pathogens, not healthcare workers from the patient's infection.
• B. Droplet precautions are insufficient because tuberculosis is spread by much smaller particles that remain airborne over longer distances.
• D. Contact precautions are for organisms transmitted by touch, not for airborne spread of tuberculosis.

This presentation is classic for red man syndrome, a non-IgE-mediated reaction caused by direct mast cell and basophil degranulation triggered by rapid vancomycin infusion, leading to histamine release and the characteristic flushing and rash. It is not a true anaphylactic reaction and does not require stopping the drug permanently. Management involves slowing the infusion rate to at least 60 minutes per gram, giving an antihistamine such as diphenhydramine, and then resuming the infusion once symptoms resolve. Nephrotoxicity presents later with rising creatinine rather than acute flushing during infusion, and epinephrine is reserved for true anaphylaxis with hypotension or airway compromise.

• B. Permanent discontinuation is unnecessary since the reaction is rate-related and resolves with slower infusion, not a contraindication to the drug.
• C. This presentation reflects an infusion reaction, not nephrotoxicity, which presents with rising creatinine rather than acute flushing.
• D. Epinephrine is reserved for true IgE-mediated anaphylaxis with hypotension or airway compromise, which is not present here.

Aminoglycosides such as gentamicin are concentrated in renal proximal tubular cells and the inner ear, causing dose- and duration-dependent nephrotoxicity and ototoxicity (both vestibular and cochlear). Nephrotoxicity is usually reversible and is monitored by serial serum creatinine and trough levels, with elevated troughs indicating drug accumulation and increased toxicity risk. Ototoxicity can be irreversible, so baseline and periodic audiometry are recommended, especially with prolonged courses or in patients with renal impairment. Electrolyte, liver, and hematologic monitoring are not the primary tools for detecting aminoglycoside toxicity.

• B. Electrolyte monitoring does not detect the characteristic nephrotoxicity or ototoxicity of aminoglycosides.
• C. Aminoglycosides do not characteristically cause bone marrow suppression, so a complete blood count is not the main monitoring test.
• D. Aminoglycosides are not primarily hepatotoxic, so liver function monitoring is not the key surveillance tool.

Beta-lactam antibiotics such as ampicillin inhibit bacterial cell wall synthesis by binding penicillin-binding proteins (transpeptidases), blocking peptidoglycan cross-linking. The most common resistance mechanism in Enterobacteriaceae like Klebsiella pneumoniae is production of beta-lactamase enzymes, which hydrolyze the beta-lactam ring, rendering the antibiotic inactive before it reaches its target. This differs from altered penicillin-binding protein affinity, which is the main mechanism in methicillin-resistant Staphylococcus aureus, and from porin loss or efflux pumps, which reduce drug entry or increase drug removal but do not chemically inactivate the antibiotic.

• A. Altered penicillin-binding proteins reduce drug binding affinity rather than chemically inactivating the drug, and is the main mechanism in MRSA, not typical Klebsiella resistance.
• C. Reduced porin expression limits drug entry into the cell but does not involve enzymatic inactivation of the antibiotic.
• D. Efflux pumps physically remove the drug from the cell rather than hydrolyzing it and are not the principal resistance mechanism described here.

Antibiotic stewardship principles call for de-escalation once culture and sensitivity results identify the causative organism, narrowing therapy to the most effective agent with the narrowest spectrum. Here the organism is methicillin-sensitive Staphylococcus aureus, for which an anti-staphylococcal penicillin such as cloxacillin (or cefazolin) is more effective and has a narrower spectrum than vancomycin or piperacillin-tazobactam. Continuing broad-spectrum empirical therapy unnecessarily increases the risk of resistance, toxicity, and cost. Stopping all antibiotics is inappropriate since an organism requiring a full treatment course has been identified, and adding further gram-negative coverage is unwarranted since no gram-negative organism was isolated.

• A. No gram-negative organism was isolated, so broadening coverage further is unnecessary and contrary to de-escalation principles.
• B. Discontinuing treatment entirely is inappropriate because a bacteremic infection requiring a full antibiotic course has been confirmed.
• C. Continuing broad-spectrum dual therapy once a susceptible organism is identified promotes resistance and is inconsistent with stewardship principles.

Surgical site infection prophylaxis is most effective when the antibiotic achieves adequate serum and tissue concentrations at the time of incision, which is best accomplished by administering the dose within 60 minutes before incision (within 120 minutes for agents like vancomycin or fluoroquinolones that require longer infusion times). Giving the antibiotic too early allows levels to decline before the critical period of bacterial contamination, while giving it after incision or closure fails to provide protection during the period of greatest risk. Prophylaxis should not be withheld until signs of infection appear, as its purpose is prevention rather than treatment.

• A. Giving the dose three hours beforehand allows serum levels to fall below effective concentrations by the time of incision.
• C. Prophylaxis is intended to prevent infection and must be given before contamination occurs, not withheld until infection is already apparent.
• D. Administering the antibiotic after skin closure provides no protection during the surgery itself, when contamination risk is highest.

Confidentiality is a core duty in medical ethics, but it is not absolute when there is a identifiable third party at serious, foreseeable risk of harm, such as a spouse exposed to HIV. The preferred approach follows the duty-to-warn principle: the physician should first counsel the patient extensively about the health implications and strongly encourage voluntary disclosure to his partner, offering support such as couples counselling. If the patient persists in refusing to disclose despite counselling, and a specific identifiable person remains at ongoing risk, public health authorities may be involved to ensure partner notification through established protocols, balancing patient autonomy with protection of the partner's health. This stepwise approach is consistent with international guidelines and Saudi MOH communicable disease reporting practice.

• A. Confidentiality may be overridden when there is a serious, identifiable risk to a third party, so treating it as absolute is ethically incorrect.
• B. Breaching confidentiality unilaterally without first attempting counselling and voluntary disclosure, or without following due process, violates the patient's rights.
• D. Taking no action ignores the physician's duty to protect a specific identifiable person at serious ongoing risk of harm.